Cybin
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cybin and other ETFs, options, and stocks.About CYBN
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.
CEOEric So
CEOEric So
Employees50
Employees50
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2016
Founded2016
Employees50
Employees50
CYBN Key Statistics
Market cap312.84M
Market cap312.84M
Price-Earnings ratio-1.62
Price-Earnings ratio-1.62
Dividend yield—
Dividend yield—
Average volume670.47K
Average volume670.47K
High today—
High today—
Low today—
Low today—
Open price$6.01
Open price$6.01
Volume10.19K
Volume10.19K
52 Week high$10.73
52 Week high$10.73
52 Week low$4.81
52 Week low$4.81
Stock Snapshot
With a market cap of 312.84M, Cybin(CYBN) trades at $6.35. The stock has a price-to-earnings ratio of -1.62.
On 2025-12-12, Cybin(CYBN) stock opened at $6.01, reached a high of —, and a low of —.
The Cybin(CYBN)'s current trading volume is 10.19K, compared to an average daily volume of 670.47K.
During the past year, Cybin(CYBN) stock moved between $4.81 at its lowest and $10.73 at its peak.
During the past year, Cybin(CYBN) stock moved between $4.81 at its lowest and $10.73 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CYBN. This list is generated using Robinhood data, and it’s not a recommendation.